A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer

Clinical trial NCT00697060 · WITHDRAWN

Trial details

NCT number: NCT00697060
Sponsor: AmpliMed Corporation
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung

Start date: 2010-08-01
Primary completion: 2011-08-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.